X-47242288-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001371072.1(USP11):c.1386G>A(p.Pro462Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00263 in 1,210,278 control chromosomes in the GnomAD database, including 110 homozygotes. There are 1,020 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0029 ( 11 hom., 95 hem., cov: 23)
Exomes 𝑓: 0.0026 ( 99 hom. 925 hem. )
Consequence
USP11
NM_001371072.1 synonymous
NM_001371072.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.24
Genes affected
USP11 (HGNC:12609): (ubiquitin specific peptidase 11) Protein ubiquitination controls many intracellular processes, including cell cycle progression, transcriptional activation, and signal transduction. This dynamic process, involving ubiquitin conjugating enzymes and deubiquitinating enzymes, adds and removes ubiquitin. Deubiquitinating enzymes are cysteine proteases that specifically cleave ubiquitin from ubiquitin-conjugated protein substrates. This gene encodes a deubiquitinating enzyme which lies in a gene cluster on chromosome Xp11.23 [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant X-47242288-G-A is Benign according to our data. Variant chrX-47242288-G-A is described in ClinVar as [Benign]. Clinvar id is 716704.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-47242288-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0627 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP11 | NM_001371072.1 | c.1386G>A | p.Pro462Pro | synonymous_variant | Exon 10 of 21 | ENST00000377107.7 | NP_001358001.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00289 AC: 325AN: 112519Hom.: 11 Cov.: 23 AF XY: 0.00277 AC XY: 96AN XY: 34677
GnomAD3 genomes
AF:
AC:
325
AN:
112519
Hom.:
Cov.:
23
AF XY:
AC XY:
96
AN XY:
34677
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00669 AC: 1215AN: 181725Hom.: 38 AF XY: 0.00608 AC XY: 403AN XY: 66337
GnomAD3 exomes
AF:
AC:
1215
AN:
181725
Hom.:
AF XY:
AC XY:
403
AN XY:
66337
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00260 AC: 2855AN: 1097707Hom.: 99 Cov.: 32 AF XY: 0.00255 AC XY: 925AN XY: 363075
GnomAD4 exome
AF:
AC:
2855
AN:
1097707
Hom.:
Cov.:
32
AF XY:
AC XY:
925
AN XY:
363075
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00287 AC: 323AN: 112571Hom.: 11 Cov.: 23 AF XY: 0.00273 AC XY: 95AN XY: 34739
GnomAD4 genome
AF:
AC:
323
AN:
112571
Hom.:
Cov.:
23
AF XY:
AC XY:
95
AN XY:
34739
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at